Kropz PLC Admission of Shares and Total Voting Rights

RNS Number : 4832I

Kropz PLC

17 October 2024

 

 17 October 2024

 

Kropz plc

 

("Kropz" or the "Company")

 

Admission of Fundraising Shares
and
Total Voting Rights

 

Kropz plc (AIM: KRPZ), an emerging African phosphate producer, announces that the 643,873,018 new Ordinary Shares ("New Ordinary Shares") to be issued pursuant to the Fundraising will be admitted to trading on AIM ("Admission") and dealings in respect of the New Ordinary Shares will commence at 8.00 a.m. on 18 October 2024.

 

Following Admission, the Company's issued share capital will be 1,567,591,241 Ordinary Shares. This figure of 1,567,591,241 may then be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information visit www.kropz.com or contact:

Kropz Plc	Via Tavistock
Louis Loubser (CEO)	[phone]
Grant Thornton UK LLP	Nominated Adviser
Samantha Harrison  Harrison Clarke  Ciara Donnelly	[phone]
Hannam & Partners	Broker
Andrew Chubb  Ernest Bell	[phone]
Tavistock	Financial PR & IR (UK)
Nick Elwes  Jos Simson	[phone]  [e-mail]
R&A Strategic Communications	PR (South Africa)
Charmane Russell  Marion Brower	[phone]  [e-mail]   [e-mail]

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCQKABNPBDDOKD